Expression of NEAT1 can be used as a predictor for Dex resistance in multiple myeloma patients
Abstract Objective Multiple myeloma is a heterogeneous disorder and the intratumor genetic heterogeneity contributes to emergency of drug resistance. Dexamethasone has been used clinically for decades for MM. Nevertheless, their use is severely hampered by the risk of developing side effects and the...
Main Authors: | Yuyue Ren, Yijun Liu, Wanting He, Weiwei Zhao, Jiaqi Pan, Haiyan Gao, Yuying Li, Ying Zhang, Wei Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-07-01
|
Series: | BMC Cancer |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12885-023-11084-x |
Similar Items
-
Identification of long noncoding RNA NEAT1 as a key gene involved in the extramedullary disease of multiple myeloma by bioinformatics analysis
by: Ting Chen, et al.
Published: (2023-12-01) -
PURPL and NEAT1 Long Non-Coding RNAs Are Modulated in Vascular Smooth Muscle Cell Replicative Senescence
by: Clara Rossi, et al.
Published: (2023-12-01) -
The lncRNA NEAT1 activates Wnt/β-catenin signaling and promotes colorectal cancer progression via interacting with DDX5
by: Meng Zhang, et al.
Published: (2018-09-01) -
Long non-coding RNA Neat1 and paraspeckle components are translational regulators in hypoxia
by: Anne-Claire Godet, et al.
Published: (2022-12-01) -
PTRF/Cavin-1 as a Novel RNA-Binding Protein Expedites the NF-κB/PD-L1 Axis by Stabilizing lncRNA NEAT1, Contributing to Tumorigenesis and Immune Evasion in Glioblastoma
by: Kaikai Yi, et al.
Published: (2022-01-01)